MedPath

安丘市鲁安药业有限责任公司

Ownership
-
Established
1998-12-07
Employees
-
Market Cap
-
Website
http://www.luanpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

51

NMPA:51

Drug Approvals

Oryzanol Tablets

Product Name
谷维素片
Approval Number
国药准字H37020410
Approval Date
Feb 6, 2025
NMPA

Piracetam Tablets

Product Name
吡拉西坦片
Approval Number
国药准字H37020256
Approval Date
Feb 6, 2025
NMPA

Chlorpheniramine Maleate Tablets

Product Name
马来酸氯苯那敏片
Approval Number
国药准字H37020412
Approval Date
Feb 6, 2025
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H20093782
Approval Date
Feb 7, 2024
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H37020420
Approval Date
Jul 23, 2020
NMPA

Hydrotalcite

Product Name
铝碳酸镁
Approval Number
国药准字H10950018
Approval Date
Jul 23, 2020
NMPA

Ibuprofen Tablets

Product Name
布洛芬片
Approval Number
国药准字H37020243
Approval Date
Jul 23, 2020
NMPA

Glucurolactone Tablets

Product Name
葡醛内酯片
Approval Number
国药准字H37020421
Approval Date
Jul 23, 2020
NMPA

Paracetamol

Product Name
对乙酰氨基酚
Approval Number
国药准字H37020656
Approval Date
Jul 23, 2020
NMPA

Paracetamol and Pseudoephedrine Hydrochloride Tablets(II)

Product Name
新爱得
Approval Number
国药准字H10960003
Approval Date
Jul 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.